These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15448912)

  • 1. [Treatment of sialorrhea with botulinum toxin: an overview].
    Hagenah J; Kahl KG; Steinlechner S; Lencer R; Klein C
    Nervenarzt; 2005 Apr; 76(4):418-25. PubMed ID: 15448912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.
    Petracca M; Guidubaldi A; Ricciardi L; Ialongo T; Del Grande A; Mulas D; Di Stasio E; Bentivoglio AR
    Toxicon; 2015 Dec; 107(Pt A):129-40. PubMed ID: 26327120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin as an effective treatment of clozapine-induced hypersalivation.
    Kahl KG; Hagenah J; Zapf S; Trillenberg P; Klein C; Lencer R
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):229-30. PubMed ID: 14747903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
    Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
    Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
    Verma A; Steele J
    Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
    Ondo WG; Hunter C; Moore W
    Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins.
    Narayanaswami P; Geisbush T; Tarulli A; Raynor E; Gautam S; Tarsy D; Gronseth G
    Parkinsonism Relat Disord; 2016 Sep; 30():73-7. PubMed ID: 27406786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations.
    Tan EK
    Eur J Neurol; 2006 Feb; 13 Suppl 1():60-4. PubMed ID: 16417600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea.
    Steinlechner S; Klein C; Moser A; Lencer R; Hagenah J
    Psychopharmacology (Berl); 2010 Jan; 207(4):593-7. PubMed ID: 19823807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial.
    Chinnapongse R; Gullo K; Nemeth P; Zhang Y; Griggs L
    Mov Disord; 2012 Feb; 27(2):219-26. PubMed ID: 21887710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin.
    Egevad G; Petkova VY; Vilholm OJ
    J Parkinsons Dis; 2014; 4(3):321-6. PubMed ID: 24919823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Radiation Therapy and Botulinum Toxin Injections in the Management of Sialorrhea in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review.
    Shehee L; O'Rourke A; Garand KL
    J Clin Neuromuscul Dis; 2020 Jun; 21(4):205-221. PubMed ID: 32453096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological strategies for clozapine-induced hypersalivation: treatment with botulinum toxin B in one patient and review of the literature].
    Kahl KG; Trillenberg P; Kordon A; Lencer R; Klein C; Hagenah J
    Nervenarzt; 2005 Feb; 76(2):205-8. PubMed ID: 15448913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B; Aslami B; Backes H
    Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary gland application of botulinum toxin for the treatment of sialorrhea.
    Fuster Torres MA; Berini Aytés L; Gay Escoda C
    Med Oral Patol Oral Cir Bucal; 2007 Nov; 12(7):E511-7. PubMed ID: 17978775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis.
    Stone CA; O'Leary N
    J Pain Symptom Manage; 2009 Feb; 37(2):246-58. PubMed ID: 18676117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The option of sonographic guidance in Botulinum toxin injection for drooling in Parkinson's disease.
    Jost WH
    J Neural Transm (Vienna); 2016 Jan; 123(1):51-5. PubMed ID: 26138438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Botulinum neurotoxin type A treatment for sialorrhea change oral health?
    Tiigimäe-Saar J; Taba P; Tamme T
    Clin Oral Investig; 2017 Apr; 21(3):795-800. PubMed ID: 27114092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease.
    Contarino MF; Pompili M; Tittoto P; Vanacore N; Sabatelli M; Cedrone A; Rapaccini GL; Gasbarrini G; Tonali PA; Bentivoglio AR
    Parkinsonism Relat Disord; 2007 Jul; 13(5):299-303. PubMed ID: 16807056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin B reduces sialorrhea in parkinsonism.
    Racette BA; Good L; Sagitto S; Perlmutter JS
    Mov Disord; 2003 Sep; 18(9):1059-61. PubMed ID: 14502678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.